HCV Infection

This research paper is going to review today’s silent killer, the Hepatitis C virus. This paper will talk about the description of the disease, the signs and symptoms, the etiology and risk factors, diagnostic studies, treatments and prognosis of this disease. I had lived with this disease for over ten years before diagnosed so it is important to understand the signs and symptoms so the disease can be identified and a treatment plan can be identified as the sooner it is treated the more likely it will eradicate the disease.

Hepatitis C virus (HCV) is from the virus family Flaviviridae with an RNA envelope serving as it's genetic material. The genetic material (RNA) is HCV's pathogenic structure. The genome is positive sense single stranded RNA, which is very similar to mRNA and can be translated quickly to the host cell (Bauman 2012). Hepatitis C is an enveloped virus, and the RNA also lacks a proofreading ability after replication, which results in mutations coding for many genotypes within the host. This genetic variability makes it difficult for the host immune system to clear all the HCV infections. As one infection clears, another strain is being produced (Bauman 2012). The HCV antibody detected by ELISA(Wilkinson

Hepatitis C affects millions worldwide. Hepatitis C causes infection leading to chronic liver disease. Human hepatocyte chimeric mice were made by transplantation of the human hepatocyte to mice. Reverse genetic hepatitis C viruses of two different genotypes were made from infectious clones and human hepatocyte chimeric mice. Chimeric mice were injected with both genotypes of hepatitis C. There after treatment by interferon was administered. A control of human serum from a donor with chronic hepatitis C was used. The results obtained showed that mice injected with both genotypes of hepatitis C virus had a quantifiable level of virus present in the blood. It was observed that genotype 1 did not response to interferon therapy as compared to genotype 2. Results showed a decreased level of genotype 2 of hepatitis C virus after

HPV (Human Papillomavirus) is a sexually transmitted infection. HPV is transmitted through vaginal, anal, and oral sex with someone who has the virus. There are many ways to be sure that you could be safe against HPV such as abstinence, get one or both of the vaccinations (Cervarix or Gardasil), and use condoms. Although condoms are not 100% guaranteed, it is still safe to take the precaution.

The hepatitis C virus (HCV) is the most widespread blood borne infection throughout the United States. It is estimated that nearly 3.2 million Americans are chronically infected (Centers for Disease Control and Prevention, 2014). HCV is a leading cause of cirrhosis, hepatocellular carcinoma, and is an indication for liver transplant (Medscape, 2012). As a result, HCV poses a significant economic burden on the American health care system.

Nwakamma stated, “Routes of infection include organ transplantation, IV drug use, sexual contact, exposure to blood, perinatal transmission or occupational exposure” (Nwakamma). Organ transplantation was one of the first ways scientists were able to determine the cause of Hepatitis C. Another more common way Hepatitis C is still being spread is by IV drug use. If a IV needle is contaminated with infected blood, that can cause the person using it to get hepatitis C. When people are injecting drugs into their bodies using someone else’s needle, they are putting themselves at high risk to contract any infectious virus. Infectious viruses are not visible on objects but they are visible once they enter in your bloodstream. The formation of the virus is identified as a positive stranded RNA. Nwakamma makes a similar point about the description of the virus by stating, “The Hepatitis C virus is a small, enveloped, single-stranded RNA virus of the family Flaviviridae, and has a genome of approximately ten-thousand nucleotides coding for structural proteins” (Nwakamma). Once the Hepatitis C virus binds to a cell surface receptor that leads to viral entry into the host cell. Due to Flaviviridae being an RNA virus, it cannot replicate in the nucleus. Patients whose condition with Hepatitis C becomes chronic often have a hard time producing insulin. In accordance with the previous

CDC 's national strategy to prevent HCV infection includes 1) prevention of transmission during high-risk activities (e.g., injection-drug use and unprotected sex with multiple partners) through risk-reduction counseling, testing, and appropriate medical management of infected persons; 2) donor screening and product inactivation procedures to eliminate transmission from blood, blood products, donor organs, and tissue; and 3) improved infection control practices to further reduce risk of transmission during medical procedures † (10).

Hepatitis C typically has a slower and more insidious onset. The preicteric phase, the first of three phases, precedes jaundice that last from 1 - 21 days. When symptom do occur they can be so vague that people often don't realize what is truly going on. People actually may mistake these symptoms as a mild case of the influenza virus as the symptoms of this phase often mimic the symptoms of the flu. The interic phase is characterized by the onset of jaundice that last 2 - 4 weeks. Urine often becomes dark and stool may be a abnormally light color, this is cause by the absence of bile in the stool. Bile pigment deposits in the skin can cause pruritus to occur. The liver often becomes enlarged and tender. During the third phase, the posticteric

A bloodborne pathogen is an infection within the human blood that is caused by bacteria leading to harmful diseases and viruses. Bloodborne pathogens are spread through direct or indirect contact, and respiratory or vector borne transmission.

Hepatocellular carcinoma (HCC) is introduced as the fifth most common tumor and also the third most common cause of cancer-related deaths all around the world. Carcinogenesis of HCC is a multistep and complex process; it is known that multiple risk factors, such as chronic hepatitis B virus (HBV)or hepatitis C virus (HCV) infections, carcinogen exposure, cirrhosis and a group of single nucleotide polymorphisms, subscribe to hepatocarcinogenesis.Chronic HCV patients are susceptible to hepatic inflammation, developing liver fibrosis, cirrhosis and HCC. Such a case does not depend on virus genotype or viral load

According to the National Notifiable Diseases Surveillance System, there are 140 new cases and 2203 existing cases (Australian Health Department, 2016). This information has been accessed from their website and carries data from 1991 to 2015.

Hepatitis C viral (HCV) infection is one of the many chronic illnesses that disproportionately affect the 2 million persons currently incarcerated in US jails and prisons. (ACA, 2015). HCV is most frequently acquired through exposure to infected blood in persons who injected drugs any time in their lifetime. Offenders are statistically at increased risk for bloodborne pathogen infections such as HCV because of the strong association of chronic addiction and criminal behavior. Correctional health care systems have more patients with HCV infection, on a percentage basis, than any other major health care system in the United States.

Hepatitis C is an inflammation of the liver’s cells and tissues caused by the hepatitis C virus (HCV).

Based on the research made by the World Health Organization or WHO, every year 3 to 4 million people are infected by hepatitis C virus or HCV and more than 350,000 die every year because of this chronic disease. Fortunately, due to the introduction of direct-acting antivirals, treatment for HCV has been improved dramatically. Some of these medications have troublesome side effects that can interfere with the normal daily activities. Here are simple and practical tips that can help in managing and reducing these side effects:

HCV entry is the first step of interactions between virus and the target cell that is required for initiation of infection. Several host cell surface molecules including glycosaminoglycans, CD81, scavenger receptor class B type I (SRBI), members of the claudin family (CLDN1, 6 and 9) and mannose-binding lectins DC-SIGN and L-SIGN have been identified as putative HCV receptors orcoreceptorsas shown in Figure 2(Barth et al., 2006).